Tarsus Pharmaceuticals TARS
NASDAQ TARS
$73.00 -2.46 (-3.26%)
At close: Oct 2, 2026 · 4:00 PM EDT

Tarsus Pharmaceuticals (TARS) Non Operating Investment Income (2023 - 2026)

Updated

Tarsus Pharmaceuticals (TARS) reported Non Operating Investment Income of $2.81 million for Q2 2026.

Analysis

Tarsus Pharmaceuticals (TARS) Non Operating Investment Income (2023 - 2026) Analysis & Trends

For FY2024, Tarsus Pharmaceuticals posted Non Operating Investment Income of -$591,000.

  • By year, Non Operating Investment Income came in at $259,000 in FY2023 and -$268,000 in FY2022.
  • The Q2 2026 figure ranks as the lowest quarterly Non Operating Investment Income since Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Tarsus Pharmaceuticals 3.16 Bn 2.10 Bn 161.80 Mn 2.81 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.81 Mn
Jun 30, 2024 -6,000.00
Dec 31, 2023 420,000.00
Sep 30, 2023 -111,000.00
Jun 30, 2023 15,000.00
API Access

Tarsus Pharmaceuticals Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=TARS&period=max&api_key=YOUR_API_KEY